I have a BSc in Psychology from the University of the West of Scotland, and a MSc in Neural and Behavioural Sciences from the University of Tübingen. I begin working alongside the IMH in 2023, when I started as a Research Assistant Psychologist for the Bipolar At Risk Trial, a multi-centre randomised control trial investigating the efficacy of a novel cognitive behavioural therapy intervention in comparison to treatment as usual in young adults at high risk of developing Bipolar Disorder, under the supervision of the study’s Principal Investigator, Professor Matthew Broome, and Co-Lead, Dr. Emma Černis. I then got a new position in June 2024 as a Clinical Studies Officer, under the Mental Health Mission. I’m currently working on the ADEPP study, which is a randomised controlled trial looking at the use of antidepressant for the prevention of depression following first episode psychosis, and the PIMS Trial which is double-blind randomised placebo trial that investigates an inflammation in First Episode Psychosis patients, and the effects an anti-inflammatory drug has on it.